FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

773863001: Antidementia therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726821015 Antidementia therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3726822010 Antidementia therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antidementia therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Medicinal product acting as antidementia agent (product) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing only tacrine in oral dose form (medicinal product form) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing only donepezil and memantine in oral dose form (medicinal product form) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tacrine 20 milligram/1 each conventional release oral capsule Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely memantine hydrochloride 5 milligram/1 each conventional release oral tablet Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely donepezil hydrochloride 5 milligram/1 each conventional release oral tablet Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely donepezil hydrochloride 10 milligram/1 each conventional release oral tablet Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rivastigmine (as rivastigmine tartrate) 1.5 milligram/1 each conventional release oral capsule Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rivastigmine (as rivastigmine tartrate) 3 milligram/1 each conventional release oral capsule Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rivastigmine (as rivastigmine tartrate) 4.5 milligram/1 each conventional release oral capsule Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing donepezil and memantine in oral dose form (medicinal product form) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing only memantine in oral dose form (medicinal product form) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing memantine in oral dose form (medicinal product form) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely donepezil hydrochloride 23 milligram/1 each conventional release oral tablet Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rivastigmine (as rivastigmine tartrate) 6 milligram/1 each conventional release oral capsule Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tacrine 10 milligram/1 each conventional release oral capsule Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing only rivastigmine in oral dose form (medicinal product form) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely memantine hydrochloride 10 milligram/1 each conventional release oral tablet Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely galantamine (as galantamine hydrobromide) 4 milligram/1 each conventional release oral tablet Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rivastigmine (as rivastigmine tartrate) 2 milligram/1 milliliter conventional release oral solution Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tacrine 30 milligram/1 each conventional release oral capsule Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely galantamine (as galantamine hydrobromide) 8 milligram/1 each conventional release oral tablet Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely galantamine (as galantamine hydrobromide) 12 milligram/1 each conventional release oral tablet Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing only galantamine in oral dose form (medicinal product form) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing donepezil in oral dose form (medicinal product form) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing tacrine in oral dose form (medicinal product form) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing galantamine in oral dose form (medicinal product form) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tacrine 40 milligram/1 each conventional release oral capsule Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing only donepezil in oral dose form (medicinal product form) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing rivastigmine in oral dose form (medicinal product form) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing rivastigmine in transdermal dose form (medicinal product form) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing only rivastigmine in transdermal dose form (medicinal product form) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely memantine hydrochloride 21 milligram/1 each prolonged-release oral capsule (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely memantine hydrochloride 28 milligram/1 each prolonged-release oral capsule (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely memantine hydrochloride 7 milligram/1 each prolonged-release oral capsule (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely memantine hydrochloride 14 milligram/1 each prolonged-release oral capsule (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely galantamine (as galantamine hydrobromide) 4 milligram/1 milliliter conventional release oral solution (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely memantine hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely donepezil hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rivastigmine 192 microgram/1 hour prolonged-release transdermal patch (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rivastigmine 396 microgram/1 hour prolonged-release transdermal patch (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely memantine hydrochloride 20 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely galantamine (as galantamine hydrobromide) 16 milligram/1 each prolonged-release oral capsule (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely galantamine (as galantamine hydrobromide) 8 milligram/1 each prolonged-release oral capsule (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely galantamine (as galantamine hydrobromide) 24 milligram/1 each prolonged-release oral capsule (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely donepezil (as donepezil hydrochloride) 5 milligram and memantine (as memantine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely memantine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely donepezil hydrochloride 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely donepezil hydrochloride 5 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role True Antidementia therapeutic role Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start